Cargando…
Oral Levetiracetam as Add-On Therapy in Refractory Neonatal Seizures
OBJECTIVE: Seizure is the most common signs of nervous system disease in neonates. The first line of treatments in neonatal seizures (after ruling out and emergency treatment of electrolyte imbalance and hypoglycemia) are phenobarbital and phenytoin. We aimed to evaluate drugs that are more effectiv...
Autores principales: | MOLLAMOHAMMADI, Mohsen, AMIRHOSEINI, Zeinab Sadat, SAADATI, Alireza, PIRZADEH, Zahra, HASSAN AMOUZADEH, Masoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shahid Beheshti University of Medical Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160636/ https://www.ncbi.nlm.nih.gov/pubmed/30279713 |
Ejemplares similares
-
Role of Levetiracetam in Neonatal Seizure
por: Murty, Yerramilli V.S.S., et al.
Publicado: (2012) -
Experience and pharmacokinetics of Levetiracetam in Korean neonates with neonatal seizures
por: Shin, Jae Won, et al.
Publicado: (2017) -
Economic Evaluation of Add-on Levetiracetam for the Treatment of Refractory Partial Epilepsy in Korea
por: Suh, Guk-Hee, et al.
Publicado: (2009) -
Efficacy and safety of levetiracetam in the management of seizures in neonates
por: Sedighi, Mostafa, et al.
Publicado: (2016) -
Efficacy of levetiracetam for neonatal seizures in preterm infants
por: Han, Ji Yoon, et al.
Publicado: (2018)